Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

914 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Geriatric 8 screening of frailty in patients with prostate cancer.
Momota M, Hatakeyama S, Soma O, Tanaka T, Hamano I, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Imai A, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C. Momota M, et al. Among authors: imai a. Int J Urol. 2020 Aug;27(8):642-648. doi: 10.1111/iju.14256. Epub 2020 Jun 4. Int J Urol. 2020. PMID: 32500621
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y. Fujita N, et al. Among authors: imai a. Int J Clin Oncol. 2017 Dec;22(6):1087-1093. doi: 10.1007/s10147-017-1160-8. Epub 2017 Jul 5. Int J Clin Oncol. 2017. PMID: 28681153 Clinical Trial.
Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C. Fujita N, et al. Among authors: imai a. Int Urol Nephrol. 2018 Nov;50(11):1999-2005. doi: 10.1007/s11255-018-1985-8. Epub 2018 Sep 18. Int Urol Nephrol. 2018. PMID: 30229466
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C. Soma O, et al. Among authors: imai a. Med Oncol. 2019 Sep 13;36(10):88. doi: 10.1007/s12032-019-1313-x. Med Oncol. 2019. PMID: 31520152 Clinical Trial.
Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C. Fujita N, et al. Among authors: imai a. Clin Genitourin Cancer. 2020 Oct;18(5):e523-e530. doi: 10.1016/j.clgc.2020.03.009. Epub 2020 Mar 13. Clin Genitourin Cancer. 2020. PMID: 32278839
914 results